Side-by-side comparison of AI visibility scores, market position, and capabilities
SF healthcare tech with remote patient monitoring devices and AI medical billing for CCM/RPM programs; $132M General Catalyst and Sequoia backed generating $200-300/month per patient in additional practice revenue.
Athelas is a San Francisco-based healthcare technology company providing remote patient monitoring (RPM) devices and AI-powered medical billing automation for physicians managing patients with chronic conditions — enabling clinics to capture recurring CMS (Centers for Medicare & Medicaid Services) reimbursement for Chronic Care Management (CCM) and Remote Patient Monitoring programs that most practices fail to bill correctly or at all. Founded in 2016 by Tanay Tandon and Deepika Bodapati and backed with $132 million raised from General Catalyst, Sequoia Capital, and others, Athelas serves 1,000+ healthcare provider organizations with cellular-connected monitoring devices and automated billing workflow.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.